Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mehmet Ali Şendur"'
Autor:
Kadriye Bir Yücel, Emre Yekedüz, Serdar Karakaya, Deniz Tural, İsmail Ertürk, Cihan Erol, Özlem Ercelep, Nihan Şentürk Öztaş, Çağatay Arslan, Gökhan Uçar, Ahmet Küçükarda, Özlem Nuray Sever, Saadettin Kılıçkap, Orçun Can, Satı Coşkun Yazgan, Berna Öksüzoğlu, Nuri Karadurmuş, Mehmet Ali Şendur, Yüksel Ürün
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract This study aims to investigate the prognostic value of the systemic immune-inflammation index (SII)and its impact on survival in patients with metastatic renal cell carcinoma (mRCC). A total of 706patients with mRCC treated with tyrosine kin
Externí odkaz:
https://doaj.org/article/ff731989e9c14a97850334af8794a507
Autor:
Ali Alkan, Zeynep Gülsüm Güç, Mustafa Gürbüz, Güliz Özgün, Serkan Değirmencioğlu, Mutlu Doğan, Tuğba Akın Telli, Özge Keskin, Çağatay Arslan, Burak Bilgin, Sema Sezgin Göksu, Hacer Demir, Elif Berna Köksoy, Osman Köstek, İsmail Ertürk, Teoman Şakalar, Arzu Yaşar, Görkem Türkkan, Büşra Kasım, Aziz Karaoğlu, Berna Çakmak Öksüzoğlu, Fulden Yumuk, Mehmet Ali Şendur, Hasan Şenol Coşkun, İrfan Çiçin, Nuri Karadurmuş, Özgür Tanrıverdi, Hakan Akbulut, Yüksel Ürün
Publikováno v:
Journal of Men's Health, Vol 17, Iss 4, Pp 128-134 (2021)
Introduction: The efficacy and tolerability of Enzalutamide and Abiraterone Acetate have been reported in elderly patients with metastatic castration resistant prostate cancer (mCRPC). However, there is no randomized study directly comparing antitumo
Externí odkaz:
https://doaj.org/article/b4dace8ad4e24ea2ba76c16fee1bb85f
Autor:
Tuğba Başoğlu, Abdullah Sakin, Cihan Erol, Ercan Özden, Devrim Çabuk, Ebru Çılbır, Deniz Tataroğlu Özyükseler, Murat Ayhan, Mehmet Ali Şendur, Mutlu Dogan, Berna Öksüzoğlu, Melek Karakurt Eryılmaz, Özlem Er, Elif Şenocak Taşçı, Neslihan Özyurt, Özgecan Dülgar, Miraç Özen, İlhan Hacıbekiroğlu, İrem Öner, Esma Türkmen Bekmez, Hasan Çağrı Yıldırım, Şuayib Yalçın, Semra Paydaş, Emre Yekedüz, Asude Aksoy, Melike Özçelik, Abdilkerim Oyman, Elvina Almuradova, Bülent Karabulut, Nazan Demir, Murat Dinçer, Nuriye Özdemir, Dilek Erdem, Naziye Ak, Ali İnal, Derya Kıvrak Salim, Gülhan İpek Deniz, Teoman Şakalar, Ahmet Gülmez, Turgut Kaçan, Özlem Özdemir, Özkan Alan, Çağlar Ünal, Yusuf Karakaş, Serdar Turhal, Perran Fulden Yumuk
Publikováno v:
Journal of Chemotherapy. 35:142-149
Neoadjuvant chemotherapy (NACT) in gastroesophageal junction (GEJ) and gastric cancer (GC) was shown to improve survival in recent studies. We aimed to share our real-life experience of patients who received NACT to compare the efficacy and toxicity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1c2284ea2d913751fc2b471ed5ebfcc
https://doi.org/10.1080/1120009x.2022.2073159
https://doi.org/10.1080/1120009x.2022.2073159
Autor:
Emre Yekedüz, Serdar Karakaya, İsmail Ertürk, Deniz Tural, Gökhan Uçar, Nihan Şentürk Öztaş, Rukiye Arıkan, Mutlu Hızal, Ahmet Küçükarda, Özlem Nuray Sever, Çağatay Arslan, Orçun Can, Saadettin Kılıçkap, Coşkun Yazgan, Nuri Karadurmuş, Mehmet Ali Şendur, İrfan Çiçin, Umut Demirci, Mustafa Özgüroğlu, Berna Öksüzoğlu, Yüksel Ürün
Publikováno v:
Clinical genitourinary cancer.
Background: A novel prognostic model was recommended for patients with metastatic RCC (mRCC) by the International mRCC Database Consortium (IMDC). In this study, we aimed to externally validate a novel risk model for the IMDC-favorable risk group in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ebfad32a5df7fb32632e57b213e379d
https://pubmed.ncbi.nlm.nih.gov/35970759
https://pubmed.ncbi.nlm.nih.gov/35970759
Autor:
Emre Yekedüz, Deniz Tural, İsmail Ertürk, Serdar Karakaya, Cihan Erol, Özlem Ercelep, Çağatay Arslan, Özlem Nuray Sever, Saadettin Kılıçkap, Nihan Şentürk Öztaş, Ahmet Küçükarda, Orçun Can, Berna Öksüzoğlu, Mehmet Ali Şendur, Nuri Karadurmuş, Yüksel Ürün
Publikováno v:
Journal of cancer research and clinical oncology. 148(12)
Background Pan-immune-inflammation value (PIV) is an easily accessible immune marker based on peripheral blood to estimate prognosis in patients with cancer. This study evaluates the prognostic value of PIV in patients with metastatic renal cell carc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b81f799bd4c98740f3f062efe6fa14d8
https://pubmed.ncbi.nlm.nih.gov/35616728
https://pubmed.ncbi.nlm.nih.gov/35616728
Autor:
Kadriye Bir Yücel, Emre Yekedüz, Serdar Karakaya, Deniz Tural, İsmail Ertürk, Cihan Erol, Özlem Ercelep, Nihan Şentürk Öztaş, Çağatay Arslan, Gökhan Uçar, Ahmet Küçükarda, Özlem Nuray Sever, Saadettin Kılıçkap, Orçun Can, Satı Coşkun Yazgan, Berna Öksüzoğlu, Nuri Karadurmuş, Mehmet Ali Şendur, Yüksel Ürün
Aim: To investigate the prognostic value of the systemic immune-inflammation index (SII) and its impact on survival in patients with metastatic renal cell carcinoma (mRCC).Methods: A total of 706 patients with mRCC treated with tyrosine kinase inhibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47ceeff5353d62130ac9436e3a2c2201
https://doi.org/10.21203/rs.3.rs-1101225/v1
https://doi.org/10.21203/rs.3.rs-1101225/v1
Autor:
Mutlu, Hızal, Burak, Bilgin, Mehmet Ali, Şendur, Şebnem, Yücel, Seda, Kahraman, Cihan, Erol, Bülent, Akıncı, Didem, Şener Dede, Efnan, Algın, Bülent, Yalçın
Publikováno v:
Tuberkuloz ve toraks. 69(3)
Lung cancer is the most common cancer type and the leading cause of cancer-related mortality worldwide. The positivity rate of the anaplastic lymphoma kinase (ALK) mutation in non-small cell lung cancer (NSCLC) patients has been reported as 3-7%. Thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9c21eff479166b4cbbc25409a17558a8
https://pubmed.ncbi.nlm.nih.gov/34581153
https://pubmed.ncbi.nlm.nih.gov/34581153
Autor:
Dincer Aydin, Umut Kefeli, Melike Ozcelik, Gokmen Umut Erdem, Mehmet Ali Sendur, Mahmut Emre Yildirim, Basak Bala Oven, Ahmet Bilici, Mahmut Gumus
Publikováno v:
Medicina, Vol 59, Iss 8, p 1472 (2023)
Background and Objectives: Small bowel adenocarcinomas (SBAs) are rare tumors of the gastrointestinal system. Lymph node metastasis in patients with curatively resected SBAs is associated with poor prognosis. In this study, we determined the prognost
Externí odkaz:
https://doaj.org/article/3b3c8278b97c4da0b5c9f034616c34e9